Kinnevik AB (publ) Q3 2023 significant ownership

Kinnevik AB (publ) is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Kinnevik AB (publ) Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
RECURSION PHARMACEUTICALS, INC.	May 22, 2023	10,405,668	5.6%
Babylon Holdings Ltd	November 14, 2022	115,433,522	18.6%
Teladoc Health, Inc.	April 15, 2021	7,491,124	4.9%
Livongo Health, Inc.^{Sold out}	November 03, 2020	0	0.0%
MILLICOM INTERNATIONAL CELLULAR SA^{Sold out}	January 21, 2020	0	0.0%

Compare quarters

Export Kinnevik AB (publ)'s holdings